Literature DB >> 9201070

Sigmoid afferent mechanisms in patients with irritable bowel syndrome.

T Lembo1, J Munakata, B Naliboff, S Fullerton, E A Mayer.   

Abstract

Up to 60% of patients with IBS have lowered perception thresholds in the rectum to balloon distension. The current study sought to test the hypothesis that IBS patients with normal perception thresholds in the rectum show hypersensitivity of afferent pathways in the sigmoid colon. Eleven healthy normal subjects and eight IBS patients with normal rectal perception thresholds underwent a balloon distension protocol in the sigmoid and rectum. Discomfort thresholds, receptive relaxation, compliance, and referral patterns were measured. Although IBS patients had significantly lower discomfort thresholds in the sigmoid when measured as volume, pressure, and wall tension, thresholds were similar to normals. Receptive relaxation and dynamic compliance were significantly decreased in IBS patients in the sigmoid. Referral patterns were similar during sigmoid distention in IBS patients in comparison to normals. Despite normal perception thresholds in rectum and sigmoid, IBS patients show evidence for alterations in rectosigmoid afferent mechanisms. In the sigmoid, this is seen in the form of reduced reflex relaxation and compliance and in the rectum in the form of altered viscerosomatic referral.

Entities:  

Mesh:

Year:  1997        PMID: 9201070     DOI: 10.1023/a:1018817132213

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

1.  Rectal afferent function in patients with inflammatory and functional intestinal disorders.

Authors:  C N Bernstein; N Niazi; M Robert; H Mertz; A Kodner; J Munakata; B Naliboff; E A Mayer
Journal:  Pain       Date:  1996-08       Impact factor: 6.961

2.  Painful irritable bowel syndrome and sigmoid contractions.

Authors:  G H Ritsema; C J Thijn
Journal:  Clin Radiol       Date:  1991-02       Impact factor: 2.350

3.  Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome.

Authors:  J Munakata; B Naliboff; F Harraf; A Kodner; T Lembo; L Chang; D H Silverman; E A Mayer
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

Review 4.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 5.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

6.  Effects of the somatostatin analogue octreotide on rectal afferent nerves in humans.

Authors:  V Plourde; T Lembo; Z Shui; J Parker; H Mertz; Y Taché; B Sytnik; E Mayer
Journal:  Am J Physiol       Date:  1993-10

7.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

Review 8.  Basic and clinical aspects of visceral hyperalgesia.

Authors:  E A Mayer; G F Gebhart
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

9.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

Authors:  H Mertz; B Naliboff; J Munakata; N Niazi; E A Mayer
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

10.  Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.

Authors:  W L Hasler; H C Soudah; C Owyang
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

View more
  13 in total

Review 1.  Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth.

Authors:  Hyo-Rang Lee; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2006-08

2.  Developmental origins of functional dyspepsia-like gastric hypersensitivity in rats.

Authors:  John H Winston; Sushil K Sarna
Journal:  Gastroenterology       Date:  2012-11-08       Impact factor: 22.682

Review 3.  Gender differences and hormonal modulation in visceral pain.

Authors:  M M Heitkemper; M Jarrett
Journal:  Curr Pain Headache Rep       Date:  2001-02

4.  Pooled analysis of brain activity in irritable bowel syndrome and controls during rectal balloon distension.

Authors:  J Sheehan; A Gaman; M Vangel; B Kuo
Journal:  Neurogastroenterol Motil       Date:  2010-11-30       Impact factor: 3.598

5.  Rectal sensorimotor dysfunction in patients with urge faecal incontinence: evidence from prolonged manometric studies.

Authors:  C L H Chan; P J Lunniss; D Wang; N S Williams; S M Scott
Journal:  Gut       Date:  2005-05-24       Impact factor: 23.059

Review 6.  Visceral hypersensitivity in irritable bowel syndrome: a summary review.

Authors:  Georg Stacher; James Christensen
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

7.  Colorectal visceral perception in diverticular disease.

Authors:  C H M Clemens; M Samsom; J Roelofs; G P van Berge Henegouwen; A J P M Smout
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 8.  A role for inflammation in irritable bowel syndrome?

Authors:  G Barbara; R De Giorgio; V Stanghellini; C Cremon; R Corinaldesi
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

9.  Characterisation of colonic accommodation in Wistar Kyoto rats with impaired gastric accommodation.

Authors:  Vicente Martínez; Mikael Ryttinger; Marita Kjerling; Maria Astin-Nielsen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-02       Impact factor: 3.000

10.  Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress.

Authors:  John H Winston; Guang-Yin Xu; Sushil K Sarna
Journal:  Gastroenterology       Date:  2009-10-01       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.